We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.24B
AUM Growth
-$83.1M
(-6.3%)
Cap. Flow
-$36.7M
Cap. Flow
% of AUM
-2.97%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$22.9M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$21.8M |
| 3 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
+$20.3M |
| 4 |
Aveanna Healthcare
AVAH
|
+$19.7M |
| 5 |
Insmed
INSM
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
+$32.3M |
| 2 |
Atea Pharmaceuticals
AVIR
|
+$24M |
| 3 |
Novavax
NVAX
|
+$18.8M |
| 4 |
Arvinas
ARVN
|
+$13M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.02% |
| 2 | Industrials | 4.68% |
| 3 | Financials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
TG Therapeutics
TGTX
$8.24B
| $16.1M | 1.3% |
414,949
-98,700
| -19% | -$3.88M |
|
27
ResMed
RMD
$30.9B
| $16.1M | 1.3% |
65,105
-11,000
| -14% | -$2.31M |
|
|
HZNP
28
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $16M | 1.29% |
170,725
+28,250
| +20% | +$2.6M |
|
|
NEUE
29
DELISTED
NeueHealth
NEUE
| $15.7M | 1.27% |
+11,400
| New | +$15.6M |
|
30
Align Technology
ALGN
$12.9B
| $15.5M | 1.26% |
25,425
-7,800
| -23% | -$4.62M |
|
31
Zimmer Biomet
ZBH
$18.6B
| $14.2M | 1.15% |
91,258
-32,857
| -26% | -$5.32M |
|
32
PTC Therapeutics
PTCT
$6.21B
| $14M | 1.14% |
332,291
-172,637
| -34% | -$7.4M |
|
|
NVTA
33
DELISTED
Invitae Corporation
NVTA
| $13.9M | 1.12% |
410,763
-162,996
| -28% | -$5.3M |
|
34
Olema Pharmaceuticals
OLMA
$988M
| $13.7M | 1.11% |
490,020
+477,120
| +3,699% | +$13.6M |
|
35
Alnylam Pharmaceuticals
ALNY
$38.6B
| $13.2M | 1.07% |
77,846
-31,900
| -29% | -$4.67M |
|
36
Nkarta
NKTX
$155M
| $13M | 1.05% |
410,580
+241,530
| +143% | +$6.96M |
|
37
Inspire Medical Systems
INSP
$1.5B
| $13M | 1.05% |
67,250
+6,750
| +11% | +$1.34M |
|
|
RPTX
38
DELISTED
Repare Therapeutics
RPTX
| $12.9M | 1.04% |
412,150
+402,150
| +4,022% | +$13.2M |
|
39
Fate Therapeutics
FATE
$267M
| $12.8M | 1.03% |
147,000
+4,500
| +3% | +$363K |
|
|
ACCD
40
DELISTED
Accolade Inc
ACCD
| $12.5M | 1.01% |
230,000
-240,750
| -51% | -$11.7M |
|
41
Johnson & Johnson
JNJ
$647B
| $11.9M | 0.97% |
72,500
| – | – |
|
|
42
Atea Pharmaceuticals
AVIR
$357M
| $11.6M | 0.94% |
538,884
-800,000
| -60% | -$24M |
|
43
UnitedHealth
UNH
$387B
| $11.5M | 0.93% |
28,800
+5,150
| +22% | +$2.05M |
|
|
JBIO
44
Jade Biosciences
JBIO
$1.15B
| $11.4M | 0.92% |
+14,286
| New | +$11.4M |
|
|
TBIO
45
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $11.4M | 0.92% |
+28,684
| New | +$10.1M |
|
46
Centene
CNC
$31.3B
| $11.2M | 0.91% |
153,975
-43,300
| -22% | -$2.97M |
|
47
Neuropace
NPCE
$490M
| $11.2M | 0.91% |
+471,966
| New | +$11M |
|
48
DexCom
DXCM
$29.3B
| $11.2M | 0.91% |
105,152
-22,500
| -18% | -$2.16M |
|
49
Abbott
ABT
$191B
| $10.9M | 0.88% |
93,948
+14,250
| +18% | +$1.66M |
|
|
SGEN
50
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.8M | 0.87% |
68,356
+15,950
| +30% | +$2.37M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Sectoral Asset Management held 139 positions worth $1.24B, down 6.3% from $1.32B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Sectoral Asset Management's Q2 2021 filing shows 26 new, 28 increased, 58 reduced and 12 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M. The largest sale was PPD, Inc. Common Stock, an estimated $32.3M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.
- Sectoral Asset Management's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M.
- Sectoral Asset Management added most to Insmed in Q2 2021, an estimated $16.1M increase.
- Sectoral Asset Management's biggest Q2 2021 reduction was Atea Pharmaceuticals, cutting an estimated $24M.
- Sectoral Asset Management fully exited PPD, Inc. Common Stock in Q2 2021, selling an estimated $32.3M.
- Sectoral Asset Management's ten largest holdings make up 21% of its $1.24B portfolio in Q2 2021.
- Sectoral Asset Management opened 26 new positions and closed 12 in Q2 2021.
- Sectoral Asset Management's portfolio value fell 6.3% quarter-over-quarter to $1.24B.
Based on Sectoral Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.